Are we sure this is 'new'? This article seems to indicate we've seen a swine & avian 'mix' before - and they attribute the 'mixing vessel' to pigs. Perhaps they moved tp a new vessel - a lab - because now they've added human flu ....the "new and improved" form:
http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/dec2007swine.htmlNew swine flu virus supports 'mixing vessel' theory
Robert Roos News Editor
Dec 20, 2007 (CIDRAP News) – A new influenza virus discovered in Missouri pigs has a combination of genes from
avian and swine flu viruses, supporting the theory that pigs can serve as a mixing vessel for flu viruses and a potential source for a human pandemic strain, according to a report published yesterday.
Researchers found that the virus, an H2N3 subtype, caused illness in experimentally infected mice and was transmissible in swine and ferrets, suggesting it has adapted to mammals, according to the report, published in the Proceedings of the National Academy of Sciences (PNAS). In addition, genetic analysis showed the virus has a mutation linked with an increased ability to infect mammals.
The discovery marks the first identification of an H2 virus in swine, according to the authors of the report. The flu pandemic of 1957-58 was caused by an H2 virus, namely H2N2. That virus was replaced by an H3N2 strain in the pandemic of 1968-69, and H2 viruses have not circulated in humans since then. Hence, people younger than 40 have little immunity to H2 viruses, scientists say.
"Our results provide further evidence for the potential of swine to promote reassortment between different influenza viruses, and the genetic and biologic properties of the H2N3 viruses described suggest that it would be prudent to establish vigilant surveillance in pigs and in workers who have occupational exposure," states the PNAS report.
It was written by scientists from Iowa State University and the US Department of Agriculture's (USDA's) Agricultural Research Service (ARS), both in Ames, Iowa; the University of Minnesota in St. Paul; and St. Jude Children's Research Hospital and the University of Tennessee, both in Memphis. The lead author is Wenjun Ma of Iowa State and the USDA.
Two incidents 5 months apart
The discovery of the new virus began with an illness outbreak in pigs at a Missouri swine nursery in September 2006, according to the report. The pigs' lungs showed obvious signs of pneumonia, and tests showed the presence of an influenza gene, but the subtype could not be determined. Samples were submitted to the ARS in Ames, where genetic sequencing and a search of a flu sequence database showed the virus subtype to be H2N3.
After the virus was subtyped, a record search revealed that another unidentified virus had been submitted in April 2006, from a 12-week-old pig at another Missouri swine farm, according to the report. Analysis by the ARS showed that this isolate too was an H2N3, and the two viruses were nearly identical.
The two outbreak sites are about 8 miles apart, according to Marie Gramer of the University of Minnesota College of Veterinary Medicine in St. Paul, a coauthor of the report. She said there was no connection between the two operations.
Phylogenetic analysis showed that the virus's hemagglutinin (HA) gene most closely matched the genes of H2 viruses isolated from North American mallard ducks, while the neuraminidase (NA) gene was closely related to that of an H4N3 virus found in blue-winged teal. Five of the other six genes were derived from swine flu viruses currently circulating in the United States, the scientists determined.
The source of the virus is unknown, but the likeliest possibility is pond water, which was used to clean barns and water the animals on both farms, according to the report. That transmission pathway has been described before.
Looking for genetic evidence of the new viruses' adaptation to mammals, the authors compared their HA genes with the HA genes from avian H2N3 viruses. They found an amino-acid substitution at position 226 that, in other H2 and H3 viruses, has been associated with adaptation of avian viruses to humans, according to the report.
To assess the new isolate's pathogenicity in swine, the scientists inoculated 20 4-week-old pigs with one of the viruses, and 3 days later housed 10 other pigs with the inoculated pigs. On necropsy, the inoculated pigs were found to have mild to moderate pneumonia, while the contact pigs had antibodies to the virus but slight or no signs of pneumonia.
The researchers also exposed mice to one of the H2N3 viruses at three different doses. Mice that received the middle or highest doses showed signs of illness, and 75% of those with the highest dose died, but none exposed to the lower doses died.
To test the virus's effect in ferrets, the scientists inoculated three 18-week-old, separately caged ferrets with it and then placed an uninfected ferret in each cage a day later. Subsequent tests showed the virus was present in all the animals, but none showed obvious signs of illness.
Reason for public health concern
The authors write that their findings are "of considerable concern to public health." In particular, the H2N3 viruses' mutation associated with an affinity for human-type cell-surface receptors and their ability to replicate and spread in swine and ferrets "suggests that the swine H2N3 viruses have undergone adaptation to the mammalian host and as such have the ability for sustained transmission."
However, the report also says that "receptor-binding changes" are not sufficient by themselves to permit avian flu viruses to successfully adapt to humans. For example, swine H1N1 flu viruses prefer human-type receptors and have occasionally infected humans but have not become established in human populations.
Gramer told CIDRAP News that no illnesses were reported among farm workers in connection with the swine cases, and no workers were tested at the time. However, serologic testing of the workers is currently being conducted under a grant from the Centers for Disease Control and Prevention, she reported.
When asked whether the newfound virus currently represents a threat to humans, Gramer replied, "No more than any other influenza virus in the world. Transmission of flu from pigs to humans is likely rare. This flu itself is rare and we don't know if it is currently circulating in this farm or any other farm in the USA. We haven't found it again."
Although pigs have long been regarded as a viral mixing vessel that could potentially produce human pandemic strains, whether this has ever happened is unclear, the PNAS report states. The 1957 and 1968 pandemic viruses both resulted from genetic reassortment of human and avian strains, but the mixing might have occurred in humans, pigs, quail, or some other host, it says.
Gregory C. Gray, MD, MPH, an Iowa infectious disease expert who was not involved in the study, says the new findings should cause public health officials "much concern" and point up the need for careful and coordinated flu surveillance in swine, poulty, and humans who work with them.
The report suggests that state and federal public health officials should work "aggressively" with the swine and poultry industries to study the prevalence of the new virus and find out whether it is infecting humans and to set up coordinated surveillance programs, said Gray, who is director of the Center for Emerging Infectious Diseases at the University of Iowa in Iowa City.
Much effort is currently devoted to the hunt for highly pathogenic flu viruses in migratory and aquatic birds, Gray continued. "Influenza surveillance in agriculture is largely managed by the industries. Our agriculture industry and human influenza surveillance are not well coordinated. We might wake up one day to find a virus like the one in this report has become endemic in our agriculture industries and a major threat to the industries as well as to man."
He added that numerous reports show that common swine flu viruses can cause severe disease in humans. "A novel virus like the one in the PNAS report, if highly transmissible between people, has potential to cause markedly more morbidity, even a pandemic," he said.
Gray has previously written about the need to include agricultural workers in seasonal flu vaccination programs, flu surveillance, and pandemic planning. "The PNAS report greatly increases our concern," he commented.
Another expert, Michael T. Osterholm, PhD, MPH, generally concurred with Gray. "I think it’s a potentially serious threat," said Osterholm, director of the University of Minnesota Center for Infectious Disease Research and Policy, publisher of CIDRAP News. "I think one of the problems we have is that we tend to think of influenza today, because of H5N1, as an Asian disease, with the roots of any future pandemic planted deep in Asia. But we have to be very careful because we don't know that."
Gramer commented that flu is very common in pigs, particularly in the spring, fall, and early winter, and is typically mild and self-limiting. "Flu surveillance in pigs is entirely voluntary," she said. Some surveillance for flu in farm workers is carried on under research grants from the CDC and the National Institutes of Health, she added.
Ma W, Vincent AL, Gramer MR, et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci 2007 Dec 26;104(52):20949-54 [Abstract]
--------------------------------------------------------------
And who are these folks at CIDRAP (created in 2001)? CIDRAP's Primary Activities
Since its founding in 2001, CIDRAP has had significant success in bringing international prominence to issues of preparedness. CIDRAP is widely recognized for its ability to continuously improve our knowledge of emerging infectious disease, share this expertise with decision makers worldwide, and serve as a credible, dependable resource for communities around the world. These activities drive the adoption of science-based best practices among professionals, and, increasingly, the public, to reduce illness and death related to infectious disease.
Pandemic Influenza Preparedness
With an emphasis on addressing emerging infectious disease issues that pose a real and significant international, national, and regional threat, CIDRAP has focused heavily on pandemic influenza preparedness.
Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS)
MCEIRS was established by the National Institutes of Health (NIH) in April 2007 and focuses on the detection, epidemiology, ecology, and transmission of avian influenza (AI) viruses with pandemic potential. MCEIRS is one of six NIH-supported centers in the United States conducting a variety of research and surveillance activities domestically and abroad. The overall goal is to enhance understanding of how AI viruses evolve, adapt, and spread among animal populations and from animals to humans. As an international, collaborative research center drawing on a wide range of technical expertise, MCEIRS also serves as a high-level scientific resource in the event of a public health emergency involving the emergence and transmission of highly pathogenic influenza virus among humans.
MCEIRS initiatives under way in North America and Southeast Asia are aimed at identifying and analyzing AI viruses in wild birds, poultry, swine, and humans having close contact with animals at high risk of infection. Specific goals include: rapid identification and characterization of AI viruses; collection and storage of viral isolates; provision of genetic and antiviral susceptibility data on highly pathogenic AI viruses; targeted research on key questions and information gaps regarding the ecology, natural history, epidemiology, and transmission of avian influenza viruses; and development of capacity-building education and training programs.
Business preparedness
CIDRAP Business Source: CIDRAP is an international leader in driving worldwide business preparedness for pandemic influenza and other infectious disease crises. CIDRAP Business Source is a subscription-based Web resource offering current, comprehensive, and authoritative information for businesses preparing for the next pandemic. Subscribers receive a biweekly electronic newsletter, the Osterholm Briefing, featuring expert context from Dr. Osterholm on pressing issues. Every other week, Osterholm Briefing Update provides timely guidance, news, and practical resources. America's top 100 companies have turned to CIDRAP for this crucial information.
National Preparedness Summits: CIDRAP continues to host highly successful international Business Preparedness for Pandemic Influenza summits. Past meetings have brought representatives from about 200 corporations and other organizations to learn from more than 40 influenza and preparedness experts. Attendees engaged in interaction and practical strategizing within and across their own business sectors. Speakers have included former Secretary of State Madeleine Albright, World Health Organization Director General Margaret Chan, Health and Human Services Secretary Michael Leavitt, former Nightline host Ted Koppel, and Centers for Disease Control and Prevention (CDC) Director Julie Gerberding.
State and local public health preparedness
Promising Practices: Pandemic Preparedness Tools: In partnership with the Pew Center on the States (PCS), CIDRAP launched
www.pandemicpractices.org in 2007. The site offers a peer-reviewed, online database that showcases local, county, and state pandemic planning. The site brings together more than 165 peer-reviewed promising practices from four countries, 26 states, and 36 counties and cities. Compiled as a resource to save communities and states time and resources, the database enables public health professionals to learn from each other and to build on their own pandemic plans. The site highlights approaches that communities across America have developed to address four key areas: models of care; communicating effectively about pandemic flu; delaying and diminishing the impact of a pandemic; and planning for at-risk populations. Users can easily find practices applicable to their communities. The database can be searched by state or topic, as well as by area of special interest, such as materials translated into multiple languages, materials that enhance personal preparedness, or toolkits for schools.
At-Risk Populations Project: Under a contract from the Association of State and Territorial Health Officials (ASTHO), CIDRAP has assisted in the development of model guidance for state, territorial, tribal, and local health officials on planning for at-risk populations during an influenza pandemic. This ground-breaking project has involved meetings in three U.S. cities with at-risk population members and stakeholder organizations, as well as distilling the input of more than 65 subject matter experts and an expert Advisory Panel. This project will result in the publication of a national guidance document to assist public health officials in their pandemic influenza planning efforts. Tools for at-risk population planning will also be included on the Promising Practices Web site.
BioWatch
CIDRAP has served as an important partner in the federal BioWatch air-monitoring program. This program is responsible for the constant monitoring for potential bioterrorism-related agents in cities throughout the United States. CIDRAP provides critical national guidance in the deployment of the BioWatch program across the country. Through its contract with the Department of Homeland Security, CIDRAP provides support for the development of national outdoor and indoor guidance documents, a national epidemiology communications network, and a suite of related program and reference documents.
CIDRAP Web Site
The CIDRAP Web site is a world-leading source of current, comprehensive, and authoritative information on category A agents and emerging infectious diseases. Over 10 million pages are accessed each year by individuals around the world. We provide current, in-depth information on bioterrorism, influenza, and new hot topics; original news stories; and comprehensive and current lists of guidelines and articles in the literature with Web links. Our site content offers a balance of public health, medical, and public policy information.
CIDRAP's staff of professionals is dedicated to ensuring that viewers have the best and latest information available by closely monitoring developments in the field and updating our original content and related links continuously. We search numerous Web sites every day—the CDC, other academic-based public health preparedness centers, professional societies, journals, news sources, and other federal, state, and local public health and emergency preparedness agencies—for the most current and relevant information. Our goal is to continue the development of an Internet-based "living textbook" on infectious disease topics.
These features make our site a "one-stop shop" for professionals who desire to keep abreast of the ever-changing infectious disease landscape. Growing numbers of users report that they look to the CIDRAP site for both late-breaking news and for resources providing in-depth information and analysis.
CIDRAP News received a 2007 Award for Excellence in Health Care Journalism from the Association of Health Care Journalists for its seven-part series, "The Pandemic Vaccine Puzzle."
Education
Dr. Osterholm teaches the School of Public Health's "Infectious Disease Prevention and Control: Current Policy Issues and Controversies" course designed to engage students in analyzing and discussing practical public health issues associated with preventing and controlling infectious diseases.
Medical Director Kristine Moore, MD, MPH, and Associate Director Jill DeBoer, MPH, have taught several courses at the University of Minnesota's Summer Public Health Institute, including a course on pandemic influenza preparedness and a course on designing and conducting tabletop exercises to enhance public health preparedness.
